Literature DB >> 10577523

Recovery of visual field function in the optic neuritis treatment trial.

J P Fang1, R H Lin, S P Donahue.   

Abstract

PURPOSE: To assess the pattern of recovery of the visual field of patients with optic neuritis and to determine whether all affected portions of the visual field recover similarly or certain portions of the visual field have greater recovery.
METHODS: We reviewed the Humphrey Visual Field (Allergan-Humphrey Inc, San Leandro, California) data from the initial and 6-month examination for the involved and fellow eyes of patients enrolled in the Optic Neuritis Treatment Trial (ONTT). The average threshold for each patient was calculated for the entire tested field and for locations within concentric rings having a radius 3, 9, 15, 21, and 27 degrees from fixation. The absolute amount of improvement and percentage improvement in average threshold between entry and the 6-month follow-up examination were determined for each patient. These measurements were compared within the concentric rings to assess patterns of recovery.
RESULTS: Patients with localized defects recovered 86%+/-20% of their initial defect in average threshold, whereas those having diffuse defects recovered an average of 85%+/-23%. The area about fixation had the greatest relative recovery of threshold (87%+/-21% at 3 degrees); the relative recovery decreased with increasing eccentricity from fixation (P<.01).
CONCLUSIONS: Patients with optic neuritis have a marked return of visual field function that does not appear to differ between patients with diffuse or localized field defects. The reduced redundancy of axons in the periphery of the field compared with near fixation may be responsible for the greater relative recovery of threshold near fixation.

Entities:  

Mesh:

Year:  1999        PMID: 10577523     DOI: 10.1016/s0002-9394(99)00297-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Ophthaproblem. Optic neuritis.

Authors:  Jason Blair; Sanjay Sharma
Journal:  Can Fam Physician       Date:  2003-10       Impact factor: 3.275

Review 2.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Authors:  Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

3.  New developments in the treatment of optic neuritis.

Authors:  Thomas M Jenkins; Ahmed T Toosy
Journal:  Eye Brain       Date:  2010-06-17

4.  Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years.

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Mariya Dontchev; Robin L Gal; Roy W Beck
Journal:  Arch Ophthalmol       Date:  2010-03

5.  Optic Neuritis.

Authors:  Laura J. Balcer
Journal:  Curr Treat Options Neurol       Date:  2001-07       Impact factor: 3.598

6.  Computerized expert system for evaluation of automated visual fields from the Ischemic Optic Neuropathy Decompression Trial: methods, baseline fields, and six-month longitudinal follow-up.

Authors:  Steven E Feldon
Journal:  Trans Am Ophthalmol Soc       Date:  2004

Review 7.  Visual fields in neuro-ophthalmology.

Authors:  Sachin Kedar; Deepta Ghate; James J Corbett
Journal:  Indian J Ophthalmol       Date:  2011 Mar-Apr       Impact factor: 1.848

8.  Comparing evolvement of visual field defect in neuromyelitis optica spectrum disorder-optic neuritis and idiopathic optic neuritis: a prospective study.

Authors:  Jiaqi Liang; Yuxin Zhang; Kaiqun Liu; Xiaoyu Xu; Xiujuan Zhao; Wei Qiu; Xinyu Zhang; Hui Yang
Journal:  BMC Ophthalmol       Date:  2022-08-09       Impact factor: 2.086

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.